3SMART Study Group.The Salmeterol Multicenter Asthma Research Trial:A Comparison of Usual Pharmacotherapy for Ashma or Usual Pharmacotherapy Plus Salmeterol[J].Chest,2006,129:15-26.
4Martinez FD.Safety of Long-Acting Beta-Agonists-An Urgent Need to Clear the Air[J].New England Journal of Medicine,2005,353(25):2637-2639.
5Johnson M, Butchers Pr, Colman RA, et al. The pharmacology of salmeterol[ J ]. Life Sci, 1993, 52 : 2131-2143.
6Anderson GP. Formoterol: pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective β2 adrenoceptor agonist bronchodilator [J ]. Life Sci, 1993, 52:2145-2160.
7Pauwels RA, Sears MR, Campbell M. Formoterol as relief medication in asthma:a worldwide safety and effectiveness trial[J]. Eur Respir J, 2003, 22:787-794.
8O' Byrne PM, Bisgaard H, Godard PP, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma[J]. Am J Respir Crit Care Med, 2005, 171 : 129-136.
9Castle W, Fuller R, Hall J, et al. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment [J ]. BMJ, 1993, 306 : 1034-1037.
10Nelson HS, Weiss ST, Bleecker ER, et al. The salmeterol multicenter asthma research trial: a comparisonoi usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol [J]. Chest, 2006, 129:15-26.
9Robertson CF, Price D, Henry R, et al. Short-course montelukast for intermittent asthma in children:a randomized controlled trial. Am J Respir Crit Care Med ,2007,175 (4) :323-329.
10Lehrer PM, Hochron SM, Mayne TM, et al. Relationship between changes in EMG and respiratory sinus arrhythmia in a study of re- laxation therapy for asthma. Appl Psychophysiol Biofeedback, 1997,22(3 ) :183-191.
